Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn

In this week’s Phispers, Novo Nordisk and Bristol Myers Squibb (BMS) struck multi-billion-dollar acquisitions to expand t...

Impressions : 239

Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer's rare lung disease drug

In news this week, Italy’s Chiesi Group announced a deal worth up to US$ 2 billion with US-based Arbor Biotechnologies to...

Impressions : 3218

Trump, Pfizer seal deal to offer drug discounts; FDA approves Eli Lilly's oral breast cancer pill

This week, US President Donald Trump announced a deal with Pfizer to sell medicines through a new federal website, TrumpRx.go...

Impressions : 632

Pfizer buys Metsera for up to US$ 7.3 bn, Roche acquires 89bio; FDA okays injectable version of Merck's Keytruda

In this week’s Phispers, Pfizer announced the acquisition of New York-based biotech Metsera for up to US$ 7.3 billion, ma...

Impressions : 1287

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

Novo targets MASH with up to US$ 5.2bn Akero buy; BMS acquires cell therapy developer Orbital for US$ 1.5 bn

Chiesi, Arbor in US$ 2 bn gene therapy deal; Lilly to invest over US$ 1 bn in India; FDA okays Boehringer's rare lung disease drug

Trump, Pfizer seal deal to offer drug discounts; FDA approves Eli Lilly's oral breast cancer pill

Pfizer buys Metsera for up to US$ 7.3 bn, Roche acquires 89bio; FDA okays injectable version of Merck's Keytruda

Sandoz's Generics Axitinib Receives Tentative Approval In US

Amneal Pharms's Generics Isotretinoin Receives Approval in US

SQ Innovation's Lasix Onyu Receives Approval In US

Boehringer Ingelheim's Jascayd Receives Approval In US

Taro's Generics Lamotrigine Receives Approval In US

Lotus's Generics Nintedanib Receives Tentative Approval In US

Annora's Generics Mirtazapine Receives Approval in US

Changzhou's Generics Doxycycline Receives Approval in US

Dr Reddys's Generics Prednisone Receives Approval in US

Annora's Generics Bupropion Hydrochloride Receives Approval in US

Enforcement Report - Week of October 8, 2025

Prothya Biosolutions Netherlands B.V.'s Fails EDQM inspection

Health Canada Issues Recalls of Sandoz's Lisinopril tablet

FDA Issues Form 483 to Aurobindo Pharmaceuticals

Enforcement Report - Week of October 1, 2025.pdf

FDA Issues Form 483 to Dr. Reddy Lab

Persōn & Covey Recieves Warning Letter

Sichuan Savory Biotechnology is on FDA Import Alert List

Guangxi Yulin Pharmaceutical is on FDA Import Alert List

Produlab Pharma B.V's Fails EDQM inspection

Aptar Recognized In Forbes' 'World's Top Companies For Women 2025

Recur Software Acquires Cognidox To Boost AI In Life Sciences

Scynexis Secures $22M Payout From GSK After Trial Dispute

Novo Nordisk Pens $2.1B Deal For Omeros' Stalled PNH Drug

Germany's Merck Tweaks Mid-Term Healthcare Unit Guidance

Court Blocks Cosette's $438M Mayne Deal Drop; Shares Surge

Lilly's Orforglipron Shows Superior Glycemic Control In Phase 3

Under The Scanner, Yet Generic Cough Syrups Hit Shelves

Vara Secures CE Mark For Sole AI Mammography Second Read

Industry Opposes CDSCO Consultation On New Drug Regulatory

Roche Challenges Natco's Generic Risdiplam Launch In India

Moderna Claims Early Victory For Cancer Antigen In Melanoma

Aspen Wins Approval to Market Lilly's Mounjaro in South Africa

Tariff Pause Eases Pressure On Drug Companies

Natco Wins Patent Battle To Launch Generic 'Risdiplam'

Trump & Co Halts Generic Drug Tariffs, Boosts Indian Pharma Stock

Zydus Gets Health Canada Approval For Liothyronine Tablets

Pharmanovia Appoints Stephan Eder As CEO

Biocon Unit Gets USFDA Nod For Genetic Anti-Bacterial Drug

Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers

Orum Names Dorin Toader to Lead Degrader–Antibody Platforms

Argenx Showcases Immunology Innovation At 2025 AANEM Meeting

Arima Study Shows Aventa Test Improves Lymphoma Diagnosis

Oxford Nanopore Unveils PromethION Plus Flow Cell & Genetics

Cryo-Cell Reports Fiscal Q3 2025 Financial Results

Quintara Bio Completes Acquisition Laragen Sanger Sequencing Unit

Eradivir's EV25 Excels Result In Phase 2a Influenza Trial

Liberate Bio Shows In Vivo CAR-M Mediated B-Cell Depletion

Turn Therapeutics Appoints Dr. Kent Kester To Board Of Directors

Tubulis Raises €308M Series C To Advance TUB-040 ADC And Pipeline

Supriya Lifescience Receives Maharashtra State Export Award

Hikal Launches HPAPI Lab At Integrated Innovation Centre, Pune

AZ Breaks Ground On $4.5B API Production Facility In Virginia

Axway Leads 2025 Gartner API Management Magic Quadrant

Jubilant Hollisterstier Launches Sterile Fill & Finish Line

Asahi Kasei Launches Sonanos Next-Gen Excipients

Axplora initiates global investments exceeding €100m in 2025

HRV Pharma Unveils Brand Mascots

Piramal Pharma Solutions Implements POD Method At Aurora API

Supriya's Ambernath Facility Secures WHO GMP certification

Under The Scanner, Yet Generic Cough Syrups Hit Shelves

Government To Enforce Law For Rigorous Quality Checks On Drugs

J&J Faces First UK Lawsuits Over Baby Powder Cancer Link

Delhi HC Asks Companies To File Chart With Details Of Banned FDCs

Government Imposes Sulfadiazine API Import Restriction

Molecular Targeting Technologies Initiate Legal Action for EB-TRT

India Accuses Balaji Amines Of Producing Pharma-Grade Chemical

WHO Warns Against 3 'Substandard' Cough Syrups In India

FDA Warns Lifevac For Marketing Unauthorized Anti-Choking Device

Biocon Gets 1 USFDA Observation For Cranbury Site

Recur Software Acquires Cognidox To Boost AI In Life Sciences

Vara Secures CE Mark For Sole AI Mammography Second Read

Industry Opposes CDSCO Consultation On New Drug Regulatory